Vijay H Naringrekar
Inventor
Stats
- 12 US patents issued
- 24 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 24 US Applications Filed
- 155 Total Citation Count
- Nov 3, 2022 Most Recent Filing
- Jun 14, 1989 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| R-PHARM US OPERATING LLC | 1
2 | 2004
2009 |
| AXCAN PHARMA INC. | 1
| 1989
|
| Otsuka Pharmaceutical Co., Ltd. | 2
6 2 3 2 | 2004
2007 2011 2013 2014 |
| BRISTOL-MYERS SQUIBB COMPANY | 2
2 1 1 2 | 2003
2006 2010 2012 2013 |
Inventor Addresses
| Address | Duration |
|---|---|
| PRINCETON, NJ, US | Aug 22, 13 - Aug 22, 13 |
| Paramus, NJ | May 30, 06 - May 30, 06 |
| Paramus, NJ, US | Mar 18, 04 - Mar 18, 04 |
| Princeton, NJ | Jul 07, 05 - May 15, 08 |
| Princeton, NJ, US | Jan 21, 10 - Sep 07, 23 |
| Suffern, NY | Oct 22, 91 - Oct 22, 91 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 24 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2023/0277,672 | 2023 | METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS | 0 |
| 2021/0338,663 | 2021 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD | 0 |
| 2020/0230,242 | 2020 | METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS | 1 |
| 2020/0061,057 | 2020 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD | 0 |
| 10265401 | 2019 | Stable subcutaneous protein formulations and uses thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.